Cargando…
Cyclotherapy: opening a therapeutic window in cancer treatment
Cyclotherapy is a promising endeavor to improve cancer treatment by tackling the dose-limiting side effects of chemotherapy, especially for cancers harboring mutations in the TP53 tumor suppressor. In this particular context, pre-treatment with a p53 activator halts proliferation in healthy tissue,...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442291/ https://www.ncbi.nlm.nih.gov/pubmed/22711025 |
_version_ | 1782243448410079232 |
---|---|
author | van Leeuwen, Ingeborg M.M. |
author_facet | van Leeuwen, Ingeborg M.M. |
author_sort | van Leeuwen, Ingeborg M.M. |
collection | PubMed |
description | Cyclotherapy is a promising endeavor to improve cancer treatment by tackling the dose-limiting side effects of chemotherapy, especially for cancers harboring mutations in the TP53 tumor suppressor. In this particular context, pre-treatment with a p53 activator halts proliferation in healthy tissue, while leaving the p53-deficient tumor susceptible to conventional chemotherapy. |
format | Online Article Text |
id | pubmed-3442291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-34422912012-09-14 Cyclotherapy: opening a therapeutic window in cancer treatment van Leeuwen, Ingeborg M.M. Oncotarget Research Perspectives Cyclotherapy is a promising endeavor to improve cancer treatment by tackling the dose-limiting side effects of chemotherapy, especially for cancers harboring mutations in the TP53 tumor suppressor. In this particular context, pre-treatment with a p53 activator halts proliferation in healthy tissue, while leaving the p53-deficient tumor susceptible to conventional chemotherapy. Impact Journals LLC 2012-06-16 /pmc/articles/PMC3442291/ /pubmed/22711025 Text en Copyright: © 2012 van Leeuwen http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited |
spellingShingle | Research Perspectives van Leeuwen, Ingeborg M.M. Cyclotherapy: opening a therapeutic window in cancer treatment |
title | Cyclotherapy: opening a therapeutic window in cancer treatment |
title_full | Cyclotherapy: opening a therapeutic window in cancer treatment |
title_fullStr | Cyclotherapy: opening a therapeutic window in cancer treatment |
title_full_unstemmed | Cyclotherapy: opening a therapeutic window in cancer treatment |
title_short | Cyclotherapy: opening a therapeutic window in cancer treatment |
title_sort | cyclotherapy: opening a therapeutic window in cancer treatment |
topic | Research Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442291/ https://www.ncbi.nlm.nih.gov/pubmed/22711025 |
work_keys_str_mv | AT vanleeuweningeborgmm cyclotherapyopeningatherapeuticwindowincancertreatment |